Neuland Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Neuland Laboratories has a total shareholder equity of ₹11.3B and total debt of ₹1.0B, which brings its debt-to-equity ratio to 8.9%. Its total assets and total liabilities are ₹16.7B and ₹5.3B respectively. Neuland Laboratories's EBIT is ₹4.3B making its interest coverage ratio 51.6. It has cash and short-term investments of ₹1.4B.
Key information
8.9%
Debt to equity ratio
₹1.01b
Debt
Interest coverage ratio | 51.6x |
Cash | ₹1.37b |
Equity | ₹11.33b |
Total liabilities | ₹5.32b |
Total assets | ₹16.65b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524558's short term assets (₹8.3B) exceed its short term liabilities (₹4.0B).
Long Term Liabilities: 524558's short term assets (₹8.3B) exceed its long term liabilities (₹1.3B).
Debt to Equity History and Analysis
Debt Level: 524558 has more cash than its total debt.
Reducing Debt: 524558's debt to equity ratio has reduced from 38.1% to 8.9% over the past 5 years.
Debt Coverage: 524558's debt is well covered by operating cash flow (316.2%).
Interest Coverage: 524558's interest payments on its debt are well covered by EBIT (51.6x coverage).